SILVER SPRING, Md.,
March 17, 2012 /PRNewswire/
-- Sunpeaks Ventures, Inc.'s (OTCBB: SNPK) (PINKSHEETS:
SNPK) (the "Company" or "Sunpeaks Ventures") wholly owned
subsidiary Healthcare Distribution Specialist, LLC ("HDS") is
pleased to announce that they have entered into an agreement with
former All-Star player and professional basketball coach,
Paul Silas, as national spokesperson
for Clotamin®. Clotamin is the world's first specialized OTC
multivitamin product designed exclusively for use by patients on
Warfarin® and other anticoagulants (blood thinners).
Coach Silas is currently a professional basketball head coach
and nominee for the Naismith Basketball Hall of Fame Class of
2012. During his 15+ year professional playing career, Silas
collected more than 10,000 points and 10,000 rebounds, won three
championship rings, and was twice named to the All-Star team.
He ranks in the Top 20 for career games played, rebounding, and
playoff rebounding. Since his retirement from active play,
Paul has spent time as a popular professional basketball television
commentator and as head coach with several professional basketball
teams.
"We couldn't be happier about having Paul as part of our team.
We noticed his name when we were shipping his Clotamin and reached
out to him about working with us and he couldn't have been nicer,"
stated Mackie A. Barch, CEO of
Sunpeaks. "We plan to launch a ad campaign featuring Paul to
help drive Clotamin into new markets and distribution
channels."
About Sunpeaks Ventures, Inc.
Sunpeaks Ventures, Inc. and its wholly owned subsidiary
Healthcare Distribution Specialists, LLC ("HDS"), is a nationally
focused, value-added distributor of specialty drugs and
over-the-counter ("OTC") branded multivitamins to the healthcare
provider market. HDS also owns and markets Clotamin®, a
specialized over-the-counter multivitamin product designed
exclusively for use by patients also on Warfarin®, a popular blood
thinner that has a long list of known adverse drug and food
interactions.
For additional information, please visit
www.sunpeaksventures.com.
Contact: Financial Insights 888-248-8491 or
info@sunpeaksventures.com
Safe Harbor Statement
Information in this document constitute forward-looking
statements or statements which may be deemed or construed to be
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. The words
"forecast", "anticipate", "estimate", "project", "intend",
"expect", "should", "believe", and similar expressions are intended
to identify forward-looking statements. These forward-looking
statements involve, and are subject to known and unknown risks,
uncertainties and other factors which could cause Sunpeaks
Ventures' actual results, performance (financial or operating) or
achievements to differ from the future results, performance
(financial or operating) or achievements expressed or implied by
such forward-looking statements. The risks, uncertainties and
other factors are more fully discussed in Sunpeaks Ventures'
filings with the U.S. Securities and Exchange Commission. All
forward-looking statements attributable to Sunpeaks Ventures herein
are expressly qualified in their entirety by the above-mentioned
cautionary statement. Sunpeaks Ventures disclaims any
obligation to update forward-looking statements contained in this
estimate, except as may be required by law.
SOURCE Sunpeaks Ventures, Inc.